Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 73Sarcoma 60Gynecologic 20Thoracic 18Breast 18Gastrointestinal 16Other solid neoplasm 14Head & Neck 12CNS 10Endocrine 8Tumor-Agnostic 7Dermatologic 6Plasma cell 3NET 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 1Lymphoma 1

Interventions

Rituximab 1371Cyclophosphamide 1296Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 461Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 254ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 227Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × pazopanib × Lymphoid × Clear all
NCT00674024 2019-11-20

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
8 enrolled
Lymphoid

Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡